A carregar...
Customized Targeted Therapy in Hodgkin Lymphoma: Hype or Hope?
Although the majority of patients with Hodgkin lymphoma (HL) are cured with primary therapy, patients with primary refractory disease or relapse after initial treatment have poor outcomes and represent an unmet medical need. Recent advances in unraveling the biology of HL have yielded a plethora of...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4023679/ https://ncbi.nlm.nih.gov/pubmed/24287071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hoc.2013.10.004 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|